vs

Side-by-side financial comparison of IDACORP INC (IDA) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

IDACORP INC is the larger business by last-quarter revenue ($360.1M vs $225.6M, roughly 1.6× Organogenesis Holdings Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 12.1%, a 7.3% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs -4.2%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $-216.2M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -7.2%).

IDACORP, Inc is an electricity holding company, incorporated in Idaho with headquarters in Boise. It comprises Idaho Power Company, IDACORP Financial and Ida-West Energy. It was formed on October 1, 1998.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

IDA vs ORGO — Head-to-Head

Bigger by revenue
IDA
IDA
1.6× larger
IDA
$360.1M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+82.3% gap
ORGO
78.1%
-4.2%
IDA
Higher net margin
ORGO
ORGO
7.3% more per $
ORGO
19.4%
12.1%
IDA
More free cash flow
ORGO
ORGO
$251.0M more FCF
ORGO
$34.8M
$-216.2M
IDA
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-7.2%
IDA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IDA
IDA
ORGO
ORGO
Revenue
$360.1M
$225.6M
Net Profit
$43.6M
$43.7M
Gross Margin
Operating Margin
14.9%
28.1%
Net Margin
12.1%
19.4%
Revenue YoY
-4.2%
78.1%
Net Profit YoY
15.1%
469.5%
EPS (diluted)
$0.78
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDA
IDA
ORGO
ORGO
Q4 25
$360.1M
$225.6M
Q3 25
$526.4M
$150.9M
Q2 25
$449.3M
$101.0M
Q1 25
$411.1M
$86.7M
Q4 24
$375.9M
$126.7M
Q3 24
$532.5M
$115.2M
Q2 24
$442.6M
$130.2M
Q1 24
$417.9M
$110.0M
Net Profit
IDA
IDA
ORGO
ORGO
Q4 25
$43.6M
$43.7M
Q3 25
$124.4M
$21.6M
Q2 25
$95.8M
$-9.4M
Q1 25
$59.6M
$-18.8M
Q4 24
$37.9M
$7.7M
Q3 24
$113.6M
$12.3M
Q2 24
$89.5M
$-17.0M
Q1 24
$48.2M
$-2.1M
Gross Margin
IDA
IDA
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
IDA
IDA
ORGO
ORGO
Q4 25
14.9%
28.1%
Q3 25
27.5%
13.7%
Q2 25
22.4%
-12.5%
Q1 25
13.4%
-30.9%
Q4 24
11.0%
8.1%
Q3 24
25.1%
5.4%
Q2 24
23.3%
-10.7%
Q1 24
11.9%
-3.5%
Net Margin
IDA
IDA
ORGO
ORGO
Q4 25
12.1%
19.4%
Q3 25
23.6%
14.3%
Q2 25
21.3%
-9.3%
Q1 25
14.5%
-21.7%
Q4 24
10.1%
6.1%
Q3 24
21.3%
10.7%
Q2 24
20.2%
-13.1%
Q1 24
11.5%
-1.9%
EPS (diluted)
IDA
IDA
ORGO
ORGO
Q4 25
$0.78
$0.31
Q3 25
$2.26
$0.11
Q2 25
$1.76
$-0.10
Q1 25
$1.10
$-0.17
Q4 24
$0.72
$0.05
Q3 24
$2.12
$0.09
Q2 24
$1.71
$-0.13
Q1 24
$0.95
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDA
IDA
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$215.7M
$93.7M
Total DebtLower is stronger
$3.3B
Stockholders' EquityBook value
$3.6B
$300.1M
Total Assets
$10.2B
$598.7M
Debt / EquityLower = less leverage
0.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDA
IDA
ORGO
ORGO
Q4 25
$215.7M
$93.7M
Q3 25
$333.2M
$63.7M
Q2 25
$474.5M
$73.1M
Q1 25
$634.5M
$110.0M
Q4 24
$368.9M
$135.6M
Q3 24
$427.9M
$94.3M
Q2 24
$169.6M
$89.9M
Q1 24
$157.6M
$88.6M
Total Debt
IDA
IDA
ORGO
ORGO
Q4 25
$3.3B
Q3 25
Q2 25
Q1 25
Q4 24
$3.1B
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
IDA
IDA
ORGO
ORGO
Q4 25
$3.6B
$300.1M
Q3 25
$3.5B
$255.1M
Q2 25
$3.4B
$233.2M
Q1 25
$3.3B
$242.9M
Q4 24
$3.3B
$262.9M
Q3 24
$3.3B
$278.5M
Q2 24
$3.2B
$263.5M
Q1 24
$2.9B
$278.0M
Total Assets
IDA
IDA
ORGO
ORGO
Q4 25
$10.2B
$598.7M
Q3 25
$10.1B
$509.8M
Q2 25
$9.9B
$461.1M
Q1 25
$9.6B
$467.4M
Q4 24
$9.2B
$497.9M
Q3 24
$9.1B
$446.3M
Q2 24
$8.7B
$443.2M
Q1 24
$8.3B
$458.5M
Debt / Equity
IDA
IDA
ORGO
ORGO
Q4 25
0.93×
Q3 25
Q2 25
Q1 25
Q4 24
0.92×
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDA
IDA
ORGO
ORGO
Operating Cash FlowLast quarter
$137.8M
$39.4M
Free Cash FlowOCF − Capex
$-216.2M
$34.8M
FCF MarginFCF / Revenue
-60.0%
15.4%
Capex IntensityCapex / Revenue
98.3%
2.1%
Cash ConversionOCF / Net Profit
3.16×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-577.5M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDA
IDA
ORGO
ORGO
Q4 25
$137.8M
$39.4M
Q3 25
$162.8M
$3.1M
Q2 25
$176.9M
$-32.9M
Q1 25
$124.3M
$-19.9M
Q4 24
$136.4M
$10.9M
Q3 24
$201.9M
$8.7M
Q2 24
$146.4M
$4.7M
Q1 24
$109.7M
$-10.2M
Free Cash Flow
IDA
IDA
ORGO
ORGO
Q4 25
$-216.2M
$34.8M
Q3 25
$-127.9M
$844.0K
Q2 25
$-156.4M
$-36.5M
Q1 25
$-77.0M
$-23.6M
Q4 24
$-48.9M
$7.6M
Q3 24
$-16.1M
$6.1M
Q2 24
$-199.6M
$2.9M
Q1 24
$-150.3M
$-12.4M
FCF Margin
IDA
IDA
ORGO
ORGO
Q4 25
-60.0%
15.4%
Q3 25
-24.3%
0.6%
Q2 25
-34.8%
-36.1%
Q1 25
-18.7%
-27.2%
Q4 24
-13.0%
6.0%
Q3 24
-3.0%
5.3%
Q2 24
-45.1%
2.2%
Q1 24
-36.0%
-11.3%
Capex Intensity
IDA
IDA
ORGO
ORGO
Q4 25
98.3%
2.1%
Q3 25
55.2%
1.5%
Q2 25
74.2%
3.6%
Q1 25
49.0%
4.2%
Q4 24
49.3%
2.7%
Q3 24
41.0%
2.2%
Q2 24
78.2%
1.4%
Q1 24
62.2%
2.0%
Cash Conversion
IDA
IDA
ORGO
ORGO
Q4 25
3.16×
0.90×
Q3 25
1.31×
0.14×
Q2 25
1.85×
Q1 25
2.08×
Q4 24
3.60×
1.43×
Q3 24
1.78×
0.71×
Q2 24
1.63×
Q1 24
2.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IDA
IDA

Retailrevenues$323.0M90%
Transmissionserviceswheeling$18.6M5%
Energyefficiencyprogramrevenues$11.7M3%
Wholesaleenergysales$10.5M3%
Otherrevenues$9.5M3%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons